142 related articles for article (PubMed ID: 33506899)
21. Mining Prognostic Biomarkers of Hepatocellular Carcinoma Based on Immune-Associated Genes.
Chen W; Tang D; Ou M; Dai Y
DNA Cell Biol; 2020 Apr; 39(4):499-512. PubMed ID: 32069130
[TBL] [Abstract][Full Text] [Related]
22. Development and validation of a 14-gene signature for prognosis prediction in hepatocellular carcinoma.
Zhang BH; Yang J; Jiang L; Lyu T; Kong LX; Tan YF; Li B; Zhu YF; Xi AY; Xu X; Yan LN; Yang JY
Genomics; 2020 Jul; 112(4):2763-2771. PubMed ID: 32198063
[TBL] [Abstract][Full Text] [Related]
23. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
[TBL] [Abstract][Full Text] [Related]
24. A gene-based risk score model for predicting recurrence-free survival in patients with hepatocellular carcinoma.
Wang W; Wang L; Xie X; Yan Y; Li Y; Lu Q
BMC Cancer; 2021 Jan; 21(1):6. PubMed ID: 33402113
[TBL] [Abstract][Full Text] [Related]
25. A five lncRNA signature for prognosis prediction in hepatocellular carcinoma.
Sun Y; Zhang F; Wang L; Song X; Jing J; Zhang F; Yu S; Liu H
Mol Med Rep; 2019 Jun; 19(6):5237-5250. PubMed ID: 31059056
[TBL] [Abstract][Full Text] [Related]
26. Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients.
Zhu GQ; Yang Y; Chen EB; Wang B; Xiao K; Shi SM; Zhou ZJ; Zhou SL; Wang Z; Shi YH; Fan J; Zhou J; Liu TS; Dai Z
J Transl Med; 2019 Jun; 17(1):203. PubMed ID: 31215439
[TBL] [Abstract][Full Text] [Related]
27. Promising key genes associated with tumor microenvironments and prognosis of hepatocellular carcinoma.
Pan L; Fang J; Chen MY; Zhai ST; Zhang B; Jiang ZY; Juengpanich S; Wang YF; Cai XJ
World J Gastroenterol; 2020 Feb; 26(8):789-803. PubMed ID: 32148377
[TBL] [Abstract][Full Text] [Related]
28. Bioinformatic Analysis to Identify a Multi-mRNA Signature for the Prediction of Metastasis in Hepatocellular Carcinoma.
Liu L; Wang B; Han Q; Zhen C; Li J; Qu X; Wang F; Kong X; Zheng L
DNA Cell Biol; 2020 Nov; 39(11):2028-2039. PubMed ID: 33147069
[TBL] [Abstract][Full Text] [Related]
29. Analysis of clinical significance and prospective molecular mechanism of main elements of the JAK/STAT pathway in hepatocellular carcinoma.
Wang X; Liao X; Yu T; Gong Y; Zhang L; Huang J; Yang C; Han C; Yu L; Zhu G; Qin W; Liu Z; Zhou X; Liu J; Han Q; Peng T
Int J Oncol; 2019 Oct; 55(4):805-822. PubMed ID: 31485610
[TBL] [Abstract][Full Text] [Related]
30. Identification and Validation of Immune-Related Gene Prognostic Signature for Hepatocellular Carcinoma.
Chen W; Ou M; Tang D; Dai Y; Du W
J Immunol Res; 2020; 2020():5494858. PubMed ID: 32211443
[TBL] [Abstract][Full Text] [Related]
31. Characterization of long non-coding RNAs to reveal potential prognostic biomarkers in hepatocellular carcinoma.
Ma Y; Luo T; Dong D; Wu X; Wang Y
Gene; 2018 Jul; 663():148-156. PubMed ID: 29684484
[TBL] [Abstract][Full Text] [Related]
32. New strategies in hepatocellular carcinoma: genomic prognostic markers.
Villanueva A; Hoshida Y; Toffanin S; Lachenmayer A; Alsinet C; Savic R; Cornella H; Llovet JM
Clin Cancer Res; 2010 Oct; 16(19):4688-94. PubMed ID: 20713493
[TBL] [Abstract][Full Text] [Related]
33. Identification and Characterization of Genes Related to the Prognosis of Hepatocellular Carcinoma Based on Single-Cell Sequencing.
Chen W; Zhang F; Xu H; Hou X; Tang D; Dai Y
Pathol Oncol Res; 2022; 28():1610199. PubMed ID: 36091935
[TBL] [Abstract][Full Text] [Related]
34. A Four-Methylated lncRNAs-Based Prognostic Signature for Hepatocellular Carcinoma.
Liao LE; Hu DD; Zheng Y
Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32784402
[TBL] [Abstract][Full Text] [Related]
35. A microRNA expression profile for vascular invasion can predict overall survival in hepatocellular carcinoma.
Lin Z; Cai YJ; Chen RC; Chen BC; Zhao L; Xu SH; Wang XD; Song M; Wu JM; Wang YQ; Zhou MT; Shi KQ
Clin Chim Acta; 2017 Jun; 469():171-179. PubMed ID: 28365450
[TBL] [Abstract][Full Text] [Related]
36. Systematic profiling of a novel prognostic alternative splicing signature in hepatocellular carcinoma.
Zhang D; Duan Y; Wang Z; Lin J
Oncol Rep; 2019 Dec; 42(6):2450-2472. PubMed ID: 31578577
[TBL] [Abstract][Full Text] [Related]
37. Development of an oncogenic dedifferentiation SOX signature with prognostic significance in hepatocellular carcinoma.
Li MM; Tang YQ; Gong YF; Cheng W; Li HL; Kong FE; Zhu WJ; Liu SS; Huang L; Guan XY; Ma NF; Liu M
BMC Cancer; 2019 Aug; 19(1):851. PubMed ID: 31462277
[TBL] [Abstract][Full Text] [Related]
38. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
Gene; 2019 May; 698():9-18. PubMed ID: 30825595
[TBL] [Abstract][Full Text] [Related]
39. A signature of 33 immune-related gene pairs predicts clinical outcome in hepatocellular carcinoma.
Sun XY; Yu SZ; Zhang HP; Li J; Guo WZ; Zhang SJ
Cancer Med; 2020 Apr; 9(8):2868-2878. PubMed ID: 32068352
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Biomarker Identification Through Integrating the Gene Signatures of Hepatocellular Carcinoma Properties.
Cai J; Li B; Zhu Y; Fang X; Zhu M; Wang M; Liu S; Jiang X; Zheng J; Zhang X; Chen P
EBioMedicine; 2017 May; 19():18-30. PubMed ID: 28434945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
